Andrographis Tablet

The andrographis tablet market is experiencing robust growth, driven by a global shift toward natural immune-boosting solutions. In 2026, the market for andrographis extract is valued at approximately $1.8 billion, with a projected CAGR of 8.1% through 2034 DatainteloVerifiedmarketresearch. Tablets specifically account for 14.9% of the market, favored by consumers for masking the herb's intense bitterness and providing precise dosing Dataintelo.

Key Market Trends & Insights

* Immune & Respiratory Dominance: The primary driver remains immune support and respiratory health, with clinical evidence reducing symptom duration for flu and respiratory infections DatainteloArchivemarketresearch.

* Standardization Shift: There is a clear trend toward standardized extracts, specifically targeting 10% to 98% andrographolide content to ensure potency and clinical efficacy DatainteloReportprime.

* Emerging Skincare Application: Andrographis is the fastest-growing ingredient in cosmeceuticals (9.7% CAGR), utilized for its antioxidant and anti-acne properties Dataintelo.

* Regional Growth: While the Asia-Pacific region holds a 44.7% share, North America and Europe are seeing high demand for "clean-label" and sustainably sourced herbal supplements DatainteloArchivemarketresearch.

Product & Sourcing Landscape

Suppliers are increasingly offering high-potency standardized tablets and private-label options to meet retail demand. Prices for bulk tablets typically range from $1.20 to $4.00 per unit depending on extract concentration and volume AlibabaAlibaba.

Leading Manufacturers

Key manufacturers, primarily located in China's Shaanxi and Guangdong hubs, provide extensive OEM/ODM services with certifications like GMP, ISO, and USDA to support international distribution AlibabaAlibabaAlibaba.